Skip to main content

and
  1. No Access

    Article

    Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing

    Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) has recently emerged as a top genome editing technology and has afforded investigators the ability to more easily st...

    Alexandra C. Chadwick, Kiran Musunuru in Current Atherosclerosis Reports (2017)

  2. No Access

    Article

    Genome Editing for the Study of Cardiovascular Diseases

    The opportunities afforded through the recent advent of genome-editing technologies have allowed investigators to more easily study a number of diseases. The advantages and limitations of the most prominent ge...

    Alexandra C. Chadwick, Kiran Musunuru in Current Cardiology Reports (2017)